MA28640B1 - Macrolides a liaison ester utiles pour le traitement d'infections microbiennes - Google Patents

Macrolides a liaison ester utiles pour le traitement d'infections microbiennes

Info

Publication number
MA28640B1
MA28640B1 MA29498A MA29498A MA28640B1 MA 28640 B1 MA28640 B1 MA 28640B1 MA 29498 A MA29498 A MA 29498A MA 29498 A MA29498 A MA 29498A MA 28640 B1 MA28640 B1 MA 28640B1
Authority
MA
Morocco
Prior art keywords
ester
treatment
microbial infections
linked
macrolides useful
Prior art date
Application number
MA29498A
Other languages
English (en)
Inventor
Sulejman Alihodzic
Stjepan Mutak
Drazen Pavlovic
Ivana Palej
Vlado Stimac
Samra Kapic
Adrijana Vinter
Skugor Maja Matanovic
Original Assignee
Glaxosmithkline Zagreb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Zagreb filed Critical Glaxosmithkline Zagreb
Publication of MA28640B1 publication Critical patent/MA28640B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MA29498A 2004-05-06 2006-12-01 Macrolides a liaison ester utiles pour le traitement d'infections microbiennes MA28640B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56940204P 2004-05-06 2004-05-06
US58111804P 2004-06-18 2004-06-18

Publications (1)

Publication Number Publication Date
MA28640B1 true MA28640B1 (fr) 2007-06-01

Family

ID=34967616

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29498A MA28640B1 (fr) 2004-05-06 2006-12-01 Macrolides a liaison ester utiles pour le traitement d'infections microbiennes

Country Status (16)

Country Link
US (1) US20080255060A1 (fr)
EP (1) EP1756135B1 (fr)
JP (1) JP2007536371A (fr)
AR (1) AR049269A1 (fr)
AT (1) ATE439367T1 (fr)
AU (1) AU2005240849B2 (fr)
BR (1) BRPI0510328A (fr)
CA (1) CA2566085A1 (fr)
DE (1) DE602005015963D1 (fr)
ES (1) ES2331739T3 (fr)
IL (1) IL178876A0 (fr)
MA (1) MA28640B1 (fr)
MX (1) MXPA06012923A (fr)
NO (1) NO20065662L (fr)
RU (1) RU2006143051A (fr)
WO (1) WO2005108412A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
JP2008540503A (ja) 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 細菌感染症の処置に有用なエーテル結合マクロライド
MX2009005977A (es) * 2006-12-05 2009-06-17 Pfizer Polimorfos de motilida.
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
CN107854477A (zh) 2008-10-24 2018-03-30 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
BR112012029586A2 (pt) * 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (fr) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Formulations parentérales pour l'administration d'antibiotiques macrolides
WO2014152326A1 (fr) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Procédés pour traiter des maladies respiratoires et formulations pour la mise en œuvre de ceux-ci
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
GB201608236D0 (en) 2016-05-11 2016-06-22 Fidelta D O O Seco macrolide compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds
GB0310979D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
EP1628989B1 (fr) * 2003-05-13 2006-12-20 Glaxo Group Limited Nouveaux composes a cycle ramifie en 14 et 15
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
JP2008540503A (ja) * 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 細菌感染症の処置に有用なエーテル結合マクロライド

Also Published As

Publication number Publication date
AU2005240849B2 (en) 2008-10-23
ES2331739T3 (es) 2010-01-14
BRPI0510328A (pt) 2007-10-23
EP1756135A1 (fr) 2007-02-28
MXPA06012923A (es) 2007-07-18
WO2005108412A1 (fr) 2005-11-17
AU2005240849A1 (en) 2005-11-17
JP2007536371A (ja) 2007-12-13
ATE439367T1 (de) 2009-08-15
EP1756135B1 (fr) 2009-08-12
IL178876A0 (en) 2007-03-08
CA2566085A1 (fr) 2005-11-17
AR049269A1 (es) 2006-07-12
RU2006143051A (ru) 2008-06-20
DE602005015963D1 (de) 2009-09-24
US20080255060A1 (en) 2008-10-16
NO20065662L (no) 2007-01-16

Similar Documents

Publication Publication Date Title
EP1536804A4 (fr) Ester 3'-l-valine de ?-d-2'-c-methyl-ribofuranosyl cytidine pour le traitement d'infections par des flaviviridae
EP1951272A4 (fr) Utilisation de lactobacillus pour le traitement d'infections virales
EP2063882A4 (fr) Inhibiteurs de kinase pour la prévention ou le traitement d'une infection
EP1931691A4 (fr) Inhibiteurs d'odcase pour le traitement du paludisme
ZA200710563B (en) Compounds for the treatment of multi-drug resistant bacterial infections
EP1765288A4 (fr) Methodes de traitement d'infections endobronchiques
GB0125222D0 (en) Composition for the treatment of microbial infections
EP1727530A4 (fr) Formulations topiques pour le traitement d'etats dermatologiques
EP2212853A4 (fr) Outils de réalité virtuelle pour l'élaboration de solutions de prévention des infections
EP1997048A4 (fr) Système de commande robotique d'emploi général
EP2099449A4 (fr) Composition pharmaceutique pour le traitement et la prévention d'affection impliquant l'impuissance
MA28358A1 (fr) Inhibiteurs de l'integrase du vih
EP1981431A4 (fr) Méthodes et dispositifs pour le traitement de l'apnée du sommeil et des ronflements
EP2079561A4 (fr) Attaches et bagues d'espacement pour celles-ci
MA28519B1 (fr) Inhibiteurs de l'integrase du vih
EP1771201A4 (fr) Compositions et procedes pour le traitement ou la prevention de maladie liee a l'oxalate
EP2033111A4 (fr) Implémentation de tables réflexives des contrôles d'accès sur des plates-formes distribuées
EP1750667A4 (fr) Combinaison de fosfomycine/aminoglycoside aerosolisé pour le traitement d'infections respiratoires bactériennes
EP1840830A4 (fr) Procede de traitement d'image
EP1833264A4 (fr) Procede de traitement d'image
EP1581243A4 (fr) Lactoferrine orale pour le traitement des sepsies
EP1756114A4 (fr) Inhibiteurs de l'integrase du vih
IL178876A0 (en) Ester linked macrolides useful for the treatment of microbial infections
EP1773970A4 (fr) Formules de lubrifiants pour le traitement de toles
EP2015741A4 (fr) Inhibiteurs de l'histone desacétylase pour le traitement de la neurodégénération